The Visual Performances of a Progressive Multifocal Intraocular Lens With Extended Depth of Focus
Retrospective Observational Trial on the Visual Performances of a Progressive Multifocal Intraocular Lens With Extended Depth of Focus
Sponsor: Opera CRO, a TIGERMED Group Company
Listed as NCT02740010, this observational or N/A phase trial focuses on Cataract and Presbyopia and remains completed. Sponsored by Opera CRO, a TIGERMED Group Company, it has been updated 11 times since 2020, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Apr 2021 — Jul 2024 [monthly]
Completed
Status: Recruiting → Completed
-
Jan 2021 — Apr 2021 [monthly]
Recruiting
-
Oct 2020 — Jan 2021 [monthly]
Recruiting
▶ Show 6 earlier versions
-
Feb 2020 — Oct 2020 [monthly]
Recruiting
Status: Enrolling By Invitation → Recruiting
-
Apr 2019 — Feb 2020 [monthly]
Enrolling By Invitation
Status: Completed → Enrolling By Invitation
-
Jun 2018 — Apr 2019 [monthly]
Completed
-
Apr 2018 — Jun 2018 [monthly]
Completed
Phase: NA → None
-
Feb 2018 — Apr 2018 [monthly]
Completed NA
-
Jan 2017 — Feb 2018 [monthly]
Completed NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Opera CRO, a TIGERMED Group Company
- SIFI SpA
For direct contact, visit the study record on ClinicalTrials.gov .